Voyager Therapeutics Inc.

10/20/2021 | Press release | Distributed by Public on 10/20/2021 06:59

Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy at Virtual Congress of the European Society of Gene and Cell Therapy